Federal Immunity Agreements Use Immunity Vs Transactional Immunity

In my 25 years as a federal prosecutor and now as a federal criminal defense attorney, I have watched countless witnesses, targets, and defendants grapple with the single most consequential decision they will ever face in a criminal investigation: whether to accept an immunity agreement and provide testimony against others. Immunity is not a magic wand that makes all legal exposure disappear, and the distinction between use immunity and transactional immunity is not some academic nuance that only law professors debate over coffee. I have sat on both sides of the table during proffer sessions where the precise wording of an immunity letter meant the difference between a client walking free and a client facing a multi-count indictment that could consume decades of their life. The federal immunity statutes, codified at 18 U.S.C. §§ 6001 through 6005, establish a framework that is deliberately tilted in favor of the government's ability to prosecute while still compelling testimony, and anyone who misunderstands the scope of the protection being offered is courting disaster of the highest order. I have seen seasoned business executives, career public officials, and even individuals with tangential involvement in a criminal enterprise make irrevocable mistakes because they assumed immunity meant something far broader than what the law actually provides. This article will explain with absolute clarity what separates use immunity from transactional immunity, how each operates in the real world of federal criminal practice, and what you must understand before you ever utter a word under a grant of immunity.

The Fifth Amendment guarantees that no person shall be compelled in any criminal case to be a witness against himself, and this constitutional privilege is the gravitational center around which all immunity law orbits. When the government wants your testimony badly enough, it can override your Fifth Amendment right by granting you immunity, but the Constitution requires that the immunity be coextensive with the scope of the privilege — meaning the protection must be at least as broad as the Fifth Amendment right it displaces. The Supreme Court made this unmistakably clear in Kastigar v. United States, 406 U.S. 441 (1972), when it held that use and derivative use immunity satisfies the Fifth Amendment because it prevents the government from using your compelled testimony or any evidence derived from it in a subsequent criminal prosecution. Transactional immunity, by contrast, would bar any prosecution for the entire transaction, event, or scheme about which you testified, regardless of whether the government's evidence came from your testimony or from completely independent sources. The practical difference between these two forms of immunity is enormous, and the federal system has almost entirely abandoned transactional immunity in favor of the narrower use immunity model, a reality that surprises many clients who come to my office believing that agreeing to cooperate means they will never face charges for the conduct they disclose.

How the Kastigar Framework Transformed Federal Immunity from a Shield into a Sword

Before 1970, the federal government operated under a patchwork of immunity statutes that often provided transactional immunity, meaning that once a witness testified under compulsion about a particular transaction, the government was forever barred from prosecuting that witness for any offense related to that transaction. This was an extraordinarily powerful protection for witnesses, and prosecutors in my predecessors' era frequently complained that transactional immunity gave away too much, effectively granting witnesses a license to confess to serious crimes with no fear of punishment so long as their testimony was deemed sufficiently valuable. Congress fundamentally altered this landscape with the Organized Crime Control Act of 1970, which established the modern use immunity framework now codified at 18 U.S.C. § 6002, providing that no testimony or other information compelled under an immunity order, or any information directly or indirectly derived from such testimony, may be used against the witness in any criminal case except for perjury, giving a false statement, or otherwise failing to comply with the order. The Supreme Court validated this new approach in Kastigar, holding that use and derivative use immunity provides protection coextensive with the Fifth Amendment privilege and that transactional immunity is not constitutionally required. I have seen firsthand how this shift fundamentally altered the balance of power in federal criminal investigations, because prosecutors can now compel testimony while retaining the ability to prosecute the witness using evidence developed before the immunity grant or evidence gathered from entirely independent sources after the testimony is given.

The procedural mechanism for obtaining use immunity in federal court is set forth in 18 U.S.C. § 6003, which requires the United States Attorney to apply to the district court for an order compelling testimony after obtaining approval from the Attorney General, the Deputy Attorney General, or a designated Assistant Attorney General. This is not a casual process; the statute demands that the government certify that the testimony or other information sought may be necessary to the public interest and that the individual has refused or is likely to refuse to testify on the basis of the Fifth Amendment privilege. In my years as a federal prosecutor, I submitted these certifications to Main Justice on multiple occasions, and I can tell you that the internal review is rigorous because no United States Attorney wants to explain to the Attorney General's office why an immunity grant backfired or why a witness who received immunity subsequently became a liability at trial. Once the court issues the order under § 6002, the witness must testify or face contempt sanctions, and the protective scope of the order attaches automatically to every word spoken under compulsion, creating a record that the government must later navigate with extreme caution if it ever decides to prosecute that witness for the underlying conduct.

The Vanishing Doctrine of Transactional Immunity and Where It Still Survives

Transactional immunity, which I will define precisely as a complete bar to prosecution for any offense related to the transaction about which the witness testifies, has been extinct in the federal compulsory process since the 1970 statutory reforms replaced it with use immunity. I want to be absolutely clear about this because the misconception persists among clients and even some attorneys that a federal prosecutor can offer transactional immunity in exchange for cooperation — they cannot, at least not through the statutory compulsory process under § 6002 through § 6003. The Department of Justice takes the position that transactional immunity is unnecessary to satisfy the Fifth Amendment and that granting it would confer a windfall on witnesses by immunizing conduct for which the government already possesses independent, untainted evidence. However, transactional immunity is not entirely dead in the American legal system; several states, including New York under Criminal Procedure Law § 50.10 and California under Penal Code § 1324, still provide statutory transactional immunity in certain circumstances, and I have coordinated with state prosecutors in joint federal-state investigations where the availability of broader state immunity became a pivotal strategic consideration. Additionally, and this is critical for defendants negotiating cooperation agreements, federal prosecutors can contractually agree not to prosecute certain conduct as part of a plea or cooperation agreement, which achieves a result functionally similar to transactional immunity even though it arises from contract principles rather than the immunity statutes themselves.

I have negotiated dozens of cooperation agreements where the government agreed to forgo prosecution for specific disclosed conduct in exchange for substantial assistance, and these agreements operate in a middle ground between pure use immunity and full transactional immunity. The government retains the ability to prosecute if it can prove the evidence it uses came from independent sources, but the contractual non-prosecution commitment binds the government in ways that a bare use immunity order does not, and breaching such an agreement invites a remedy from the court that can include specific performance or dismissal of the indictment. The distinction matters enormously in practice because a client who testifies under a statutory use immunity order can still be prosecuted if the government assembles a team of investigators who build a case without ever consulting the immunized testimony, a process known as creating a "clean team" that walled off the immunized statements from the prosecuting attorneys. In a contractual non-prosecution scenario, however, the government typically agrees not to prosecute the disclosed conduct at all, regardless of whether it could theoretically develop independent evidence, and this provides a level of certainty that statutory use immunity simply cannot match. I have spent countless hours explaining to clients that the difference between "we can't use your statement against you" and "we agree not to charge you for what you tell us about" is the difference between a conditional protection that requires perpetual vigilance and a negotiated resolution that allows everyone to move forward with clarity.

Strategic Calculations When Immunity Is on the Table — What Every Defendant and Witness Must Evaluate

When a federal prosecutor invites you, through your counsel, to participate in a proffer session with the prospect of immunity or a cooperation agreement, you are entering a high-stakes negotiation where every word you speak, every document you produce, and every inference you permit the government to draw will shape the trajectory of your case for years to come. The typical proffer agreement under Rule 11 of the Federal Rules of Criminal Procedure and the widely used standard proffer letter drafted by the Department of Justice provide that your statements during the proffer cannot be used against you in the government's case-in-chief, but they explicitly permit the government to use your statements for impeachment purposes if you testify inconsistently at trial and to develop investigative leads that can produce independent evidence. This is what I call the "derivative use trap," and I have seen intelligent, sophisticated clients walk directly into it because they failed to appreciate that while their exact words might be inadmissible, the government is free to follow the evidentiary trails those words reveal, subpoena records they learned about during the proffer, and interview witnesses whose identities surfaced only because of the proffer statements. The protection against derivative use is theoretically robust — the government bears the heavy burden at a Kastigar hearing of proving by a preponderance of the evidence that its case is derived from a legitimate, independent, untainted source — but in practice, establishing that the government failed to meet this burden requires litigation that is expensive, unpredictable, and reliant on judicial discretion that varies significantly across districts and circuits.

I have stood before federal judges in multiple jurisdictions arguing Kastigar motions, and I can tell you that the government's ability to demonstrate independent sourcing is often hard to dismantle because federal investigative files are voluminous, the timeline of evidence gathering can be reconstructed to support the government's narrative, and the clean team protocols, while imperfect, frequently survive judicial scrutiny. A client considering an immunity arrangement must understand that the decision is not simply about whether to tell the truth and receive protection; it is about whether the truth you tell will expose you to new lines of investigation that the government would not have pursued but for your disclosures. The government's interest in your testimony typically correlates with the seriousness of the targets it is pursuing, and if you are a smaller fish in a larger conspiracy, the calculus often favors cooperation because the government's resources are directed at higher-value defendants and the likelihood of subsequent prosecution diminishes accordingly. Conversely, if you are a primary target who the government views as the architect of the alleged scheme, an immunity grant may simply be a mechanism to lock you into a narrative that can be used against you in every conceivable way short of introducing your actual words at trial, and the decision to accept such an arrangement requires the most careful strategic assessment I can perform for a client.

FAQ

If I receive use immunity under 18 U.S.C. § 6002, can I ever be prosecuted for the conduct I testify about?

Yes, absolutely, and this is the most dangerous misconception I encounter in my practice. Use immunity protects you from the government introducing your compelled testimony or any evidence derived from it in a subsequent prosecution, but it does not bar prosecution altogether. If the government possessed independent evidence of your criminal conduct before you ever testified — such as financial records, emails, surveillance footage, or testimony from other witnesses who had not been exposed to your immunized statements — it can use all of that independent evidence to indict and convict you. Furthermore, the Department of Justice can and does create "clean teams" of prosecutors and agents who have never been exposed to your immunized testimony and who build a case against you using only untainted evidence, a practice the courts have consistently upheld as sufficient to satisfy the government's Kastigar burden. You can also be prosecuted for perjury, making false statements, or obstructing justice based on your immunized testimony itself, because the statute expressly carves out these offenses from the scope of protection.

Is transactional immunity ever available in the federal system, and can my attorney demand it during negotiations?

Statutory transactional immunity under the compulsory process of 18 U.S.C. § 6003 is not available in the federal system; Congress deliberately eliminated it in 1970 and the Supreme Court affirmed in Kastigar that the Constitution does not require it. Your attorney cannot demand transactional immunity through the statutory immunity mechanism because no United States Attorney has the authority to grant it — the statute simply does not provide for it. What your attorney can negotiate, however, is a contractual non-prosecution provision as part of a cooperation agreement or plea agreement under Rule 11(c) of the Federal Rules of Criminal Procedure, which can function similarly to transactional immunity for the specific conduct disclosed in the agreement. These contractual protections are enforceable against the government through motions to dismiss or for specific performance if the government breaches them, but they are limited to the precise scope of the agreement and do not provide the blanket protection that old-style transactional immunity once afforded. The key is that such agreements are entirely voluntary on the government's part and are typically reserved for cooperators who provide substantial assistance in the prosecution of more culpable defendants.

If you are facing a federal investigation and the government has signaled an interest in your testimony — whether through a proffer letter, a target letter, or an overture to your current counsel — the window for strategic decision-making is narrow and the consequences of missteps are permanent. In my quarter century of federal criminal practice, I have seen immunity agreements save clients from charges that would have destroyed their families and careers, and I have also seen poorly structured immunity arrangements become the instrument of a client's undoing because the scope of the protection was not fully understood or effectively negotiated. The choice between seeking use immunity, pursuing a contractual non-prosecution arrangement, or declining to cooperate and asserting the Fifth Amendment requires a meticulous analysis of the evidence the government already possesses, the evidence your testimony would generate, the likelihood of independent prosecution, and the value of your cooperation to the government's broader investigative goals. I approach every immunity negotiation with the same rigor I brought to evaluating immunity requests as a federal prosecutor, because I know precisely how the government builds its post-immunity cases, how clean teams operate, and what a Kastigar litigation strategy actually looks like when it reaches a federal courtroom. If you or your client is considering any form of immunity or cooperation with federal authorities, contact my office immediately for a confidential consultation in which we will evaluate your exposure, assess the government's likely independent evidence, and develop a strategy designed to maximize protection and minimize the risk of a prosecution that outlasts the immunity you were promised.